Innovent Biologics (Suzhou) Co. Ltd.

Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Renal & urogenital · Respiratory · Women's health

Innovent Biologics (Suzhou) Co. Ltd. is a clinical trial sponsor. It has 65 active clinical trials with 14,489 planned participants, across 15 therapeutic areas. Since 2021 it has completed 92 trials and stopped 22 early.

Trial track record · since 2021

65Active trials14,489 planned participants
92Completed7 with results posted
22Stopped early19% of finished trials

Pipeline · 65 active trials

StageTrialStatus

Questions about Innovent Biologics (Suzhou) Co. Ltd

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-04.

Approve Suite is not affiliated with Innovent Biologics (Suzhou) Co. Ltd..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.